Cyberonics: Aspire Generator Recall Won’t Affect VNS Therapy Sales

Cyberonics aims to submit a repair plan to FDA by April 2012 for its AspireHC vagus nerve stimulation therapy generator for epilepsy treatment following a recall of the device announced Aug. 15.